Sign inJoin waitlistJoin the waitlist

Craig Bunnell

Chief Medical Officer · Mass General Brigham

Credentials: · · · · ·

History

Mass General Brigham
Present

Hematology and Medical Oncology
Brigham and Women's Hospital
1993–1996
Internal Medicine
Brigham and Women's Hospital
1990–1993
Harvard School of Public Health
Harvard Medical School
1986–1990

Research

Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma
Cancer · 2003 · 593 citations
Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer
Journal of Clinical Oncology · 2001 · 285 citations
Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of serum tumor…
Journal of Clinical Oncology · 2003 · 258 citations

Eric Winer
16 papers
Mehra Golshan
11 papers
Harold Burstein
10 papers · 3 as a fellow
Nancy Lin
9 papers
Lawrence Shulman
7 papers
Ann Partridge
6 papers · 2 as a fellow
LP
Leroy Parker
6 papers
Rachel Freedman
6 papers
LH
Lyndsay Harris
5 papers
IK
Irene Kuter
4 papers
Linda Vahdat
4 papers
MM
Melissa Mallory
4 papers · 4 as a resident

Clinical trials

Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer
Principal investigator · Completed · Phase 2
Dana-Farber Cancer Institute
2004–2007
Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast Cancer
Principal investigator · Terminated · Phase 2
National Cancer Institute (NCI)
2004–2010
Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer
Principal investigator · Completed
Craig A. Bunnell, MD, MPH
2002–2004
Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer
Principal investigator · Completed · Phase 1
Dana-Farber Cancer Institute
2002–2011